VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ALNY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ALNYAlnylam Pharmaceuticals, Inc.
$143.82$19.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksALNYQuarterly Cash Flow

Alnylam Pharmaceuticals, Inc. (ALNY) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Alnylam Pharmaceuticals, Inc. (ALNY) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

ALNY Cash Flow Statement

Quarterly statement

ALNY Cash Flow Statement

Alnylam Pharmaceuticals, Inc. (ALNY) cash flow statement — 24-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations340.99M75.32M70.5M163.56M325.11M153.73M-118.31M-94.66M43.71M124.16M-81.52M-29.8M359.41M-58.99M-166.47M-131.98M-115.28M-122.82M-171.19M-150.14M
Operating CF Margin %23.39%5.83%6.04%14.91%26.03%19.87%-19.91%-15.96%8.73%18.82%-16.49%-6.78%47.89%-18.51%-52.14%-39.39%-43.62%-54.63%-80.27%-58.07%
Operating CF Growth %4.88%-51%159.59%272.78%643.84%23.82%-45.14%-217.71%-87.84%310.49%51.03%77.42%411.76%51.97%2.76%12.1%13.99%-0.79%27.36%-21.92%
Net Income2.17B164.49M205.99M186.42M251.08M-66.28M-57.48M-83.76M-111.57M-16.89M-65.94M-137.87M147.75M-276.02M-174.1M-207.49M-405.92M-277.4M-240.34M-258.46M
Depreciation & Amortization14.48M13.9M13.55M13.51M13.8M13.94M14.4M14.17M13.98M15M13.52M13.48M23.53M23.45M26.08M24.89M20.65M30.55M9.46M21.45M
Stock-Based Compensation79.12M86.63M70.15M71.63M108.21M111.68M56.71M91.64M45.8M89.29M45.35M41.99M63.94M75.8M39.95M42.77M128.12M30.47M29.29M44.58M
Deferred Taxes-1.89B2.66M9.31M-27.17M5.6M9.73M9.64M000454K-53.1M39.26M28.82M000005.58M
Other Non-Cash Items77.94M-222.65M53.19M-7.68M151.07M34.57M75.45M-42.5M64.76M86.06M46.4M98.91M59.41M24.4M27.74M21.54M137.21M60.13M90.36M51.82M
Working Capital Changes-103.15M30.3M-281.7M-73.15M-204.66M50.08M-217.05M-74.21M30.73M-49.3M-121.3M6.79M25.53M64.58M-86.14M-13.68M4.65M33.43M-59.96M-15.11M
Change in Receivables-171.28M-31.6M-110.42M184.25M-399.86M-136.91M-7.43M-59.51M-37.09M9.64M410K3.87M-107.99M-2.97M19.15M-53.27M-38.42M6.4M39.7M-59.45M
Change in Inventory913K280K-3.32M-13.86M4.98M11.14M6.21M849K5.92M6.79M22K11.99M4.79M1.99M-403K-18.98M-7.88M-9.2M1.93M-10.76M
Change in Payables95.96M61.62M-176.03M-174.85M223.51M182.15M-155.74M-62.11M83.59M74.47M-4.87M-38.67M118.74M82.74M-81.97M102.62M69.75M68.14M-48.74M39.5M
Cash from Investing-311.74M-363.46M-25.54M-37.17M501.11M-141.38M113.77M-52.91M-30.25M33.94M-67.62M-240.66M-10.76M-8.71M-76.22M-139.91M313.89M142.79M-147.42M-413.4M
Capital Expenditures-69.83M-34.68M-21.83M-23.29M-12.14M-14.29M-8.97M-9.09M-4.19M-8.02M-12.97M-15.31M-17.09M-15.92M-13.89M-21.64M-16.51M-16.05M-17.86M-21.89M
CapEx % of Revenue4.79%2.69%1.87%2.12%0.97%1.85%1.51%1.53%0.84%1.22%2.62%3.48%2.28%4.99%4.35%6.46%6.25%7.14%8.37%8.47%
Acquisitions00000000000225.35M-10.77M-7.21M-49.23M00000
Investments--------------------
Other Investing-1.2M44.92M-4.1M0-450K9.25M48.83M-117K-19.2M00-225.35M6.33M7.21M49.23M381K-5M-8.5M-75K-1K
Cash from Financing18.35M23.08M15.71M45.32M-448.35M53.76M44.08M31M102.75M131.5M28.91M39.23M33.14M53.39M46.37M63.44M297.02M30.34M34.96M292.29M
Debt Issued (Net)2.89M02.57M-61.21M-494.01M0000000000-777K136.17M00250M
Equity Issued (Net)15.46M-13.16M13.16M41.7M-130.59M81.22M49.37M36.28M108.04M132.78M25.86M30.89M24.8M49.39M42.37M56.71M153.02M22.5M27.12M45.04M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-1K36.24M-9K64.82M176.25M-27.46M-5.28M-5.28M-5.28M-1.28M3.05M8.33M8.33M4M4M7.5M7.83M7.83M7.83M-2.75M
Net Change in Cash46.34M-267.5M53.61M166M376.94M93.61M53.6M-133.85M131.31M286.61M-130.81M-220.34M375.23M-14.44M-194.15M-206.83M497.65M41.48M-285.89M-274.31M
Free Cash Flow271.15M40.64M48.67M140.26M312.97M139.44M-127.28M-103.76M39.52M116.14M-94.49M-45.1M342.32M-74.91M-180.37M-153.61M-131.79M-138.87M-189.05M-172.03M
FCF Margin %18.6%3.15%4.17%12.79%25.06%18.02%-21.42%-17.49%7.89%17.6%-19.11%-10.26%45.61%-23.5%-56.49%-45.85%-49.86%-61.77%-88.65%-66.54%
FCF Growth %-13.36%-70.85%138.24%235.19%692.02%20.06%-34.71%-130.04%-88.46%255.05%47.61%70.64%359.74%46.06%4.59%10.7%17.68%-4.34%25.23%-18.79%
FCF per Share1.960.290.351.032.281.08-0.98-0.810.310.92-0.75-0.362.61-0.60-1.45-1.25-1.08-1.15-1.57-1.44
FCF Conversion (FCF/Net Income)0.16x0.46x0.34x0.88x1.29x-2.32x2.06x1.13x-0.39x-7.35x1.24x0.22x2.43x0.21x0.96x0.64x0.28x0.44x0.71x0.58x
Interest Paid73.25M064.2M113.32M23.89M14.56M66.93M12.33M0030.95M000000000
Taxes Paid15.08M02.37M01.28M-1.87M2.97M0001.99M000000000